Topic: drug price regulator
Drug price regulator NPPA capped trade margins for 5 medical devices, including blood pressure monitoring machine, nebulizer and glucometer, resulting in a downward revision of prices from 20 July.
NPPA has issued a list of ‘overcharging cases’ under litigation, which includes matters dating back to 1997 & those where firms have moved court against the allegations.
Delhi-based Mankind Pharma & Gujarat's Intas Pharmaceuticals sold a Type 2 diabetes drug without seeking price approval from National Pharmaceutical Pricing Authority.
NPPA takes cognisance of ‘leaked’ documents saying Dr Ashok Seth bought shares from a Singapore company that supplied stents to the hospital chain.
India’s reliance on ethanol blended fuel is only set to increase in the wake of rising crude oil prices. But are we going to adapt in time?
A LocalCircles poll found that 70% of respondents felt their monthly household budget increased by 10% while 55% expected expenses to go up by another 10% in the next 3 months.
In February 2019, 72,400 SiG 716 rifles of 7.62 x 51mm calibre were contracted from SIG Sauer Inc, USA, under government's 'Buy (Global) category', through fast track procedure.
Like the car, nothing the party has done to reinvent itself has worked. Only way forward is to offer something looking towards the future, not in image of glorious past.